Vanguard Group
SIOX

Vanguard Group’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Vanguard Group’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,739,923
Closed -$757K – 4601
2022
Q4 		$757K Sell
1,739,923
-100,784
-5% -$32.7K ﹤0.01% 3995
2022
Q3 		$516K Sell
1,840,707
-257,874
-12% -$88.4K ﹤0.01% 4202
2022
Q2 		$756K Hold
2,098,581
– – ﹤0.01% 4176
2022
Q1 		$1.41M Sell
2,098,581
-50,571
-2% -$42.9K ﹤0.01% 4102
2021
Q4 		$2.77M Buy
2,149,152
+96,664
+5% +$172K ﹤0.01% 3915
2021
Q3 		$4.45M Buy
2,052,488
+104,226
+5% +$227K ﹤0.01% 3731
2021
Q2 		$5.32M Buy
1,948,262
+920,972
+90% +$2.29M ﹤0.01% 3566
2021
Q1 		$2.68M Sell
1,027,290
-74,060
-7% -$209K ﹤0.01% 3798
2020
Q4 		$3.06M Buy
+1,101,350
New +$3.21M ﹤0.01% 3548
2019
Q2 		– Sell
-21,198
Closed -$226K – 4191
2019
Q1 		$226K Sell
21,198
-9,807
-32% -$97.7K ﹤0.01% 3902
2018
Q4 		$247K Buy
31,005
+21,620
+230% +$312K ﹤0.01% 3865
2018
Q3 		$182K Buy
9,385
+680
+8% +$12.4K ﹤0.01% 4012
2018
Q2 		$157K Sell
8,705
-14,207
-62% -$210K ﹤0.01% 4007
2018
Q1 		$244K Sell
22,912
-22
-0.1% -$353 ﹤0.01% 3929
2017
Q4 		$967K Buy
22,934
+399
+2% +$17.9K ﹤0.01% 3617
2017
Q3 		$1.24M Buy
22,535
+1,106
+5% +$187K ﹤0.01% 3535
2017
Q2 		$3.98M Buy
21,429
+4,969
+30% +$871K ﹤0.01% 3173
2017
Q1 		$1.97M Buy
16,460
+625
+4% +$65.5K ﹤0.01% 3387
2016
Q4 		$1.57M Buy
15,835
+520
+3% +$54.8K ﹤0.01% 3443
2016
Q3 		$1.72M Buy
15,315
+406
+3% +$48.7K ﹤0.01% 3436
2016
Q2 		$1.53M Buy
14,909
+3,255
+28% +$325K ﹤0.01% 3469
2016
Q1 		$1.07M Sell
11,654
-96
-0.8% -$10.2K ﹤0.01% 3576
2015
Q4 		$1.69M Buy
11,750
+7,055
+150% +$918K ﹤0.01% 3455
2015
Q3 		$485K Buy
+4,695
New +$551K ﹤0.01% 3857

Other funds holding SIOX

JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Vanguard Group's SIOX Position: Q1 2023 in Review

Vanguard Group sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2023, closing a stake of 1,739,923 shares — an estimated $757K sold.

Vanguard Group first reported a position in SIOX in Q3 2015 and held it in 24 quarters. The position peaked at $5.32M in Q2 2021. 4 funds tracked by Wall St. Rank hold SIOX as of Q1 2023.

  • Vanguard Group reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Vanguard Group sold 1,739,923 Sio Gene Therapies Inc. Common Stock shares in Q1 2023, an estimated $757K.
  • Vanguard Group first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2015 and held it in 24 quarters.
  • Vanguard Group's Sio Gene Therapies Inc. Common Stock position peaked at $5.32M in Q2 2021.
  • 4 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2023.

Based on Vanguard Group's 13F filing for Q1 2023, filed 15 May 2023.